BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1635 related articles for article (PubMed ID: 28624578)

  • 1. Accuracy in Diagnosis of Celiac Disease Without Biopsies in Clinical Practice.
    Werkstetter KJ; Korponay-Szabó IR; Popp A; Villanacci V; Salemme M; Heilig G; Lillevang ST; Mearin ML; Ribes-Koninckx C; Thomas A; Troncone R; Filipiak B; Mäki M; Gyimesi J; Najafi M; Dolinšek J; Dydensborg Sander S; Auricchio R; Papadopoulou A; Vécsei A; Szitanyi P; Donat E; Nenna R; Alliet P; Penagini F; Garnier-Lengliné H; Castillejo G; Kurppa K; Shamir R; Hauer AC; Smets F; Corujeira S; van Winckel M; Buderus S; Chong S; Husby S; Koletzko S;
    Gastroenterology; 2017 Oct; 153(4):924-935. PubMed ID: 28624578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of Antibody-Based Strategies for Diagnosis of Pediatric Celiac Disease Without Biopsy.
    Wolf J; Petroff D; Richter T; Auth MKH; Uhlig HH; Laass MW; Lauenstein P; Krahl A; Händel N; de Laffolie J; Hauer AC; Kehler T; Flemming G; Schmidt F; Rodrigues A; Hasenclever D; Mothes T
    Gastroenterology; 2017 Aug; 153(2):410-419.e17. PubMed ID: 28461188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020.
    Husby S; Koletzko S; Korponay-Szabó I; Kurppa K; Mearin ML; Ribes-Koninckx C; Shamir R; Troncone R; Auricchio R; Castillejo G; Christensen R; Dolinsek J; Gillett P; Hróbjartsson A; Koltai T; Maki M; Nielsen SM; Popp A; Størdal K; Werkstetter K; Wessels M
    J Pediatr Gastroenterol Nutr; 2020 Jan; 70(1):141-156. PubMed ID: 31568151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the ESPGHAN Celiac Guidelines in a North American Pediatric Population.
    Gidrewicz D; Potter K; Trevenen CL; Lyon M; Butzner JD
    Am J Gastroenterol; 2015 May; 110(5):760-7. PubMed ID: 25823767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Pediatric Patients With Celiac Disease Based on Serology and a Classification and Regression Tree Analysis.
    Ermarth A; Bryce M; Woodward S; Stoddard G; Book L; Jensen MK
    Clin Gastroenterol Hepatol; 2017 Mar; 15(3):396-402.e2. PubMed ID: 27847281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transglutaminase IgA antibodies in a celiac disease mass screening and the role of HLA-DQ genotyping and endomysial antibodies in sequential testing.
    Sandström O; Rosén A; Lagerqvist C; Carlsson A; Hernell O; Högberg L; Ivarsson A
    J Pediatr Gastroenterol Nutr; 2013 Oct; 57(4):472-6. PubMed ID: 23783015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are ESPGHAN "biopsy-sparing" guidelines for celiac disease also suitable for asymptomatic patients?
    Trovato CM; Montuori M; Anania C; Barbato M; Vestri AR; Guida S; Oliva S; Mainiero F; Cucchiara S; Valitutti F
    Am J Gastroenterol; 2015 Oct; 110(10):1485-9. PubMed ID: 26372508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies in the diagnosis of coeliac disease: a biopsy-controlled, international, multicentre study of 376 children with coeliac disease and 695 controls.
    Wolf J; Hasenclever D; Petroff D; Richter T; Uhlig HH; Laaß MW; Hauer A; Stern M; Bossuyt X; de Laffolie J; Flemming G; Villalta D; Schlumberger W; Mothes T
    PLoS One; 2014; 9(5):e97853. PubMed ID: 24830313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celiac antibodies in children with type 1 diabetes - A diagnostic validation study.
    Lewandowska K; Ciepiela O; Szypowska A; Wyhowski J; Głodkowska-Mrówka E; Popko K; Ostafin M; Pyrżak B; Demkow U
    Autoimmunity; 2018 Mar; 51(2):81-88. PubMed ID: 29350070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease-Changing Utility of Serology and Histologic Measures: Expert Review.
    Husby S; Murray JA; Katzka DA
    Gastroenterology; 2019 Mar; 156(4):885-889. PubMed ID: 30578783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ESPGHAN 'biopsy-sparing' guidelines for celiac disease in children with low antitransglutaminase during COVID-19.
    Trovato CM; Montuori M; Cucchiara S; Oliva S
    Eur J Gastroenterol Hepatol; 2020 Dec; 32(12):1523-1526. PubMed ID: 32956181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized feeding intervention in infants at high risk for celiac disease.
    Vriezinga SL; Auricchio R; Bravi E; Castillejo G; Chmielewska A; Crespo Escobar P; Kolaček S; Koletzko S; Korponay-Szabo IR; Mummert E; Polanco I; Putter H; Ribes-Koninckx C; Shamir R; Szajewska H; Werkstetter K; Greco L; Gyimesi J; Hartman C; Hogen Esch C; Hopman E; Ivarsson A; Koltai T; Koning F; Martinez-Ojinaga E; te Marvelde C; Pavic A; Romanos J; Stoopman E; Villanacci V; Wijmenga C; Troncone R; Mearin ML
    N Engl J Med; 2014 Oct; 371(14):1304-15. PubMed ID: 25271603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.
    Silvester JA; Kurada S; Szwajcer A; Kelly CP; Leffler DA; Duerksen DR
    Gastroenterology; 2017 Sep; 153(3):689-701.e1. PubMed ID: 28545781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining antibody tests and taking into account antibody levels improves serologic diagnosis of celiac disease.
    Oyaert M; Vermeersch P; De Hertogh G; Hiele M; Vandeputte N; Hoffman I; Bossuyt X
    Clin Chem Lab Med; 2015 Sep; 53(10):1537-46. PubMed ID: 25719330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpretation of serological tests in the diagnosis of celiac disease: Anti-deamidated gliadin peptide antibodies revisited.
    Zucchini L; Giusti D; Gatouillat G; Servettaz A; Tabary T; Barbe C; Pham BN
    Autoimmunity; 2016 Sep; 49(6):414-420. PubMed ID: 27452003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to deamidated gliadin peptide in diagnosis of celiac disease in children.
    Lammi A; Arikoski P; Simell S; Kinnunen T; Simell V; Paavanen-Huhtala S; Hinkkanen A; Veijola R; Knip M; Toppari J; Vaarala O; Simell O; Ilonen J
    J Pediatr Gastroenterol Nutr; 2015 May; 60(5):626-31. PubMed ID: 25522308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective human leukocyte antigen, endomysium immunoglobulin A antibodies, and transglutaminase antibodies testing for celiac disease in children with Down syndrome.
    Wouters J; Weijerman ME; van Furth AM; Schreurs MW; Crusius JB; von Blomberg BM; de Baaij LR; Broers CJ; Gemke RJ
    J Pediatr; 2009 Feb; 154(2):239-42. PubMed ID: 18822429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease.
    Hadithi M; von Blomberg BM; Crusius JB; Bloemena E; Kostense PJ; Meijer JW; Mulder CJ; Stehouwer CD; Peña AS
    Ann Intern Med; 2007 Sep; 147(5):294-302. PubMed ID: 17785484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue transglutaminase levels above 100 U/mL and celiac disease: a prospective study.
    Mubarak A; Wolters VM; Gmelig-Meyling FH; Ten Kate FJ; Houwen RH
    World J Gastroenterol; 2012 Aug; 18(32):4399-403. PubMed ID: 22969205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating diagnostic accuracy of anti-tissue Transglutaminase IgA antibodies as first screening for Celiac Disease in very young children.
    Frulio G; Polimeno A; Palmieri D; Fumi M; Auricchio R; Piccolo E; Carandente Giarrusso P
    Clin Chim Acta; 2015 Jun; 446():237-40. PubMed ID: 25944768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 82.